Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Alvotech Eyes $450m Funding And Public Listing With SPAC Merger
Proposed Combination Would Have Initial Enterprise Value Of Around $2.25bn
08 Dec 2021
•
By
Dean Rudge
Alvotech's shares would trade on the Nasdaq • Source: Shutterstock
More from Deals
More from Business